Compounds > triazoles
Page last updated: 2024-08-24

triazoles and gsk2586184

triazoles has been researched along with gsk2586184 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hachulla, E; Kahl, L; Layton, M; Machado, D; Patel, J; Schifano, L; Staumont-Sallé, D; van Vollenhoven, RF1
Binks, MH; Griffiths, CE; Hanrott, KE; Hicks, KJ; Ludbrook, VJ; Patel, JS; Reich, K; Schifano, LA; Simeoni, M; Watson, J; Wilson, P; Wyres, MR1
Binks, M; Condreay, L; Dickson, M; Hachulla, E; Hicks, K; Kahl, L; Layton, M; Leon, G; Machado, D; Patel, J; Schifano, L; Staumont-Sallé, D; van Vollenhoven, RF; Zamuner, S1
D'Haens, GR; De Vries, LCS; Hicks, KJ; Ludbrook, VJ1

Trials

3 trial(s) available for triazoles and gsk2586184

ArticleYear
DRESS syndrome and reversible liver function abnormalities in patients with systemic lupus erythematosus treated with the highly selective JAK-1 inhibitor GSK2586184.
    Lupus, 2015, Volume: 24, Issue:6

    Topics: Adult; Azetidines; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity Syndrome; Female; Humans; Janus Kinase 1; Lupus Erythematosus, Systemic; Middle Aged; Protein Kinase Inhibitors; Randomized Controlled Trials as Topic; Triazoles

2015
Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study.
    The British journal of dermatology, 2016, Volume: 174, Issue:5

    Topics: Adolescent; Adult; Aged; Azetidines; Dermatologic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Gene Expression; Humans; Janus Kinase 1; Male; Middle Aged; Psoriasis; Quality of Life; Treatment Outcome; Triazoles; Young Adult

2016
Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus.
    Lupus, 2016, Volume: 25, Issue:13

    Topics: Administration, Oral; Adult; Azetidines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Interferons; Janus Kinase 1; Lupus Erythematosus, Systemic; Male; Middle Aged; Treatment Failure; Treatment Outcome; Triazoles; Young Adult

2016

Other Studies

1 other study(ies) available for triazoles and gsk2586184

ArticleYear
GSK2586184, a JAK1 selective inhibitor, in two patients with ulcerative colitis.
    BMJ case reports, 2017, Aug-07, Volume: 2017

    Topics: Adult; Azetidines; C-Reactive Protein; Clinical Trials as Topic; Colitis, Ulcerative; Humans; Janus Kinase 1; Leukocyte L1 Antigen Complex; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Severity of Illness Index; Triazoles

2017